NCT03604783 2024-09-19Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid TumorsSumitomo Pharma America, Inc.Phase 1 Terminated74 enrolled
NCT05905341 2023-11-08Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.PfizerPhase 1 Withdrawn
NCT02343172 2020-12-09Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With LiposarcomaNovartisPhase 1 Completed74 enrolled
NCT00413075 2015-07-08Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaValerio TherapeuticsPhase 1 Completed121 enrolled
NCT00413322 2015-07-08Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsValerio TherapeuticsPhase 1 Completed35 enrolled